Leon-Castillo A, de Boer SM, Powell ME, Mileshkin LR, et al. Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy. J Clin Oncol 2020;38:3388-3397.
PMID: 32749941